Showing results (2041-2050 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|October 17, 2022
Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formationTai Young Kim, Ji-Young Kim, Hak Cheol Kwon, et al.Antiviral Research|May 1, 1986
The chemical induction of PR (b) proteins and resistance to TMV infection in tobaccoR F White, E Dumas, P Shaw, et al.Antiviral Research|July 17, 2025
Functional characteristics of plitidepsin as an antiviral treatment against monkeypox virus infectionGuillermo Albericio, Daniel Rodríguez-Martín, Pablo Avilés, et al.Antiviral Research|June 16, 2025
RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP traffickingSameh A Gad, Doaa A Abo Elwafa, Saied A Hussein, et al.Antiviral Research|June 5, 2025
Unveiling SARS-CoV-2's heart: role, structure and inhibition of SARS-CoV-2 RNA-dependent RNA polymerasePaolo Malune, Francesca Esposito, Enzo TramontanoAntiviral Research|October 9, 2025
Ciclopirox suppresses poxvirus replication by targeting iron metabolismAnil Pant, Djamal Brahim Belhaouari, Lara Dsouza, et al.Antiviral Research|June 28, 2025
LAVR-289, a broad-spectrum antiviral, protects immunosuppressed Syrian hamsters against lethal adenovirus challengeAnn E Tollefson, Anna Cline-Smith, Vincent Roy, et al.Antiviral Research|July 23, 2025
High-throughput split-GFP antiviral screening assay against fusogenic paramyxovirusesLaura Vandemaele, Thibault Francken, Joost Schepers, et al.Antiviral Research|July 20, 2025
Cholesterol 25-hydroxylase inhibits Newcastle disease virus replication by its architectural damage and blocking HN proteinSatyendu Nandy, Siddharth Neog, Sachin KumarAntiviral Research|July 5, 2025
Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17-21, 2025Robert Jordan, Nancie M Archin, Valeria Cagno, et al.Pageof 523